Human bone marrow-derived MSCs (Catholic MASTER Cells) were obtained from the Catholic Institute of Cell Therapy (CIC, Seoul, Korea). The Catholic MASTER Cells were allogeneic MSCs certified by the KFDA. The cells were obtained by human bone marrow aspiration from the iliac crest of healthy donors between the ages of 20 and 55 years. The process was approved by the Institutional Review Board of Seoul St. Mary's Hospital (approval numbers KIRB-00344-009 and KIRB-00362-006). Bone marrow aspirated from the donor was collected and sent to the CIC under good manufacturing practice (GMP) conditions. The CIC was responsible for the isolation, expansion, and quality control of allogeneic MSCs. Detailed information on the Catholic MASTER Cells was reported in a previous study [20]. Briefly, under conditions of bacterial sterility, mycoplasma sterility, and a low endotoxin level (<3 EU/mL) in the GMP-compliant facility, cells were expanded and tested for multilineage differentiation and cell-surface antigens.

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.